• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

27.41 +0.01 (+0.04%)
Delayed Quote Updated: 10:56 AM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 76,425
Open 27.24
Bid (Size) 27.34 (200)
Ask (Size) 27.48 (100)
Prev. Close 27.40
Today's Range 26.29 - 27.44
52wk Range 10.85 - 28.11
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
October 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
September 30, 2026
New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications 
From Ceribell
Via GlobeNewswire

Performance

52-Week Range 2.5% below 52-week high
27.41
10.8552W Low 28.1152W High
1 Week 2.5% below 1-week high
24.621W Low 28.111W High

CeriBell, Inc. - Common Stock (CBLL) traded between $10.85 and $28.11 over the past 52 weeks and last traded at $27.41, 2.5% below its 52-week high. Over the past week it ranged between $24.62 and $28.11.

Past 12 Months
+9.5%
+13.0%
+68.4%
+30.2%
+28.7%
+104.7%
1W +$2.37
1M +$3.16
3M +$11.13
6M +$6.35
YTD +$6.11
1Y +$14.02

CBLL was +104.7% over the past year, +30.2% over six months, +28.7% year to date, +9.5% in the last week.

12 Months vs Market
CBLL
+104.7%
DIA
+12.2%
SPY
+14.2%
QQQ
+17.0%
IWM
+13.2%

Over the past 12 months CBLL returned +104.7% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.0% and IWM (Russell 2000) +13.2%.

Volume & Liquidity 0.19× 3-mo avg
Today 76,425 3-mo avg 408.0K
1W
494.8K
1M
414.7K
3M
408.0K
6M
377.2K
YTD
354.8K
1Y
377.9K

CBLL most recently traded 76,425 shares against a 3-month average daily volume of 408.0K.

More News

Read More
News headline image
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push ↗
August 12, 2026
Via MarketBeat
News headline image
CeriBell (CBLL) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised ↗
May 11, 2026
Via Chartmill
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook ↗
February 24, 2026
Via Chartmill
News headline image
CeriBell Q2 Earnings Call Highlights ↗
August 10, 2026
Via MarketBeat
Topics Earnings World Trade
News headline image
Ceribell Reports Second Quarter 2026 Financial Results
August 10, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
August 10, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
August 03, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
July 29, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
July 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
June 08, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
May 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗
May 15, 2026
Via MarketBeat
News headline image
CeriBell Q1 Earnings Call Highlights ↗
May 11, 2026
Via MarketBeat
Topics Earnings
News headline image
CeriBell (CBLL) Q1 2026 Earnings Transcript ↗
May 11, 2026
Via The Motley Fool
Topics World Trade
News headline image
Ceribell Reports First Quarter 2026 Financial Results
May 11, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
April 29, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
April 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q4 2025 Earnings Call Transcript ↗
February 24, 2026
Via The Motley Fool
Topics Earnings World Trade
News headline image
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in Upcoming March Investor Conferences
February 18, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
From Ceribell
Via GlobeNewswire

Frequently Asked Questions

Is CeriBell, Inc. - Common Stock publicly traded?
Yes, CeriBell, Inc. - Common Stock is publicly traded.
What exchange does CeriBell, Inc. - Common Stock trade on?
CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CeriBell, Inc. - Common Stock?
The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
What is the current price of CeriBell, Inc. - Common Stock?
The current price of CeriBell, Inc. - Common Stock is 27.41
When was CeriBell, Inc. - Common Stock last traded?
The last trade of CeriBell, Inc. - Common Stock was at 10/23/26 10:56 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap